Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Clinical Subtype | Transcriptional Subtype | Small Molecule | Antibody | Perturbagen Target | Perturbagen Class | Perturbagen Concentration | Perturbagen Conc Unit | Biological Replicate ID | Relative Cell Count | Normalized Growth Rate Inhibition Value | Nominal Division Rate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ZR75B | HR+ | Luminal | 17-AAG | HSP90 | HSP90 | 100 | uM | 9972.037 | 0.1178 | -0.7246 | 1.0789 | |
| ZR75B | HR+ | Luminal | 17-AAG | HSP90 | HSP90 | 0.16 | uM | 9997.037 | 0.5840 | 0.2933 | 1.2339 | |
| ZR75B | HR+ | Luminal | 17-AAG | HSP90 | HSP90 | 0.00128 | uM | 9972.037 | 1.0102 | 1.0189 | 1.0789 | |
| ZR75B | HR+ | Luminal | 17-AAG | HSP90 | HSP90 | 20 | uM | 9972.037 | 0.3716 | -0.2010 | 1.0789 | |
| ZR75B | HR+ | Luminal | 17-AAG | HSP90 | HSP90 | 0.000256 | uM | 9997.037 | 1.0181 | 1.0293 | 1.2339 | |
| ZR75B | HR+ | Luminal | 17-AAG | HSP90 | HSP90 | 0.032 | uM | 9997.037 | 0.8365 | 0.7305 | 1.2339 | |
| ZR75B | HR+ | Luminal | (Z)-4-Hydroxytamoxifen | ESR1 | 6.67 | uM | 9972.019 | 0.8408 | 0.6996 | 1.0654 | ||
| ZR75B | HR+ | Luminal | 17-AAG | HSP90 | HSP90 | 0.000256 | uM | 9972.037 | 1.0435 | 1.0805 | 1.0789 | |
| ZR75B | HR+ | Luminal | 17-AAG | HSP90 | HSP90 | 0.032 | uM | 9972.037 | 0.6239 | 0.2916 | 1.0789 | |
| ZR75B | HR+ | Luminal | 17-AAG | HSP90 | HSP90 | 4 | uM | 9972.037 | 0.4167 | -0.1115 | 1.0789 | |
| ZR75B | HR+ | Luminal | (Z)-4-Hydroxytamoxifen | ESR1 | 0.267 | uM | 9972.019 | 0.9773 | 0.9574 | 1.0654 | ||
| ZR75B | HR+ | Luminal | (Z)-4-Hydroxytamoxifen | ESR1 | 0.0107 | uM | 9972.019 | 1.0080 | 1.0151 | 1.0654 | ||
| ZR75B | HR+ | Luminal | 17-AAG | HSP90 | HSP90 | 0.00128 | uM | 9997.037 | 1.0468 | 1.0755 | 1.2339 | |
| ZR75B | HR+ | Luminal | 17-AAG | HSP90 | HSP90 | 0.0064 | uM | 9997.037 | 0.9653 | 0.9436 | 1.2339 | |
| ZR75B | HR+ | Luminal | (Z)-4-Hydroxytamoxifen | ESR1 | 0.00213 | uM | 9972.019 | 0.9927 | 0.9863 | 1.0654 | ||
| ZR75B | HR+ | Luminal | (Z)-4-Hydroxytamoxifen | ESR1 | 1.33 | uM | 9972.019 | 0.8992 | 0.8102 | 1.0654 | ||
| ZR75B | HR+ | Luminal | (Z)-4-Hydroxytamoxifen | ESR1 | 33.3 | uM | 9972.019 | 0.6537 | 0.3419 | 1.0654 | ||
| ZR75B | HR+ | Luminal | (Z)-4-Hydroxytamoxifen | ESR1 | 167 | uM | 9972.019 | 0.3967 | -0.1602 | 1.0654 | ||
| ZR75B | HR+ | Luminal | (Z)-4-Hydroxytamoxifen | ESR1 | 0.000427 | uM | 9972.019 | 1.0596 | 1.1117 | 1.0654 | ||
| ZR75B | HR+ | Luminal | 17-AAG | HSP90 | HSP90 | 0.0064 | uM | 9972.037 | 0.9585 | 0.9229 | 1.0789 | |
| ZR75B | HR+ | Luminal | 17-AAG | HSP90 | HSP90 | 0.16 | uM | 9972.037 | 0.4702 | -0.0063 | 1.0789 | |
| ZR75B | HR+ | Luminal | 17-AAG | HSP90 | HSP90 | 0.8 | uM | 9972.037 | 0.4289 | -0.0874 | 1.0789 | |
| ZR75B | HR+ | Luminal | (Z)-4-Hydroxytamoxifen | ESR1 | 0.0533 | uM | 9972.019 | 0.9720 | 0.9474 | 1.0654 | ||
| ZR75B | HR+ | Luminal | 17-AAG | HSP90 | HSP90 | 4 | uM | 9997.037 | 0.4938 | 0.1289 | 1.2339 | |
| ZR75B | HR+ | Luminal | 17-AAG | HSP90 | HSP90 | 0.8 | uM | 9997.037 | 0.4768 | 0.0973 | 1.2339 |